medigraphic.com
SPANISH

Revista de Enfermedades no Transmisibles Finlay

ISSN 2221-2434 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 1

<< Back Next >>

Finlay 2020; 10 (1)

Diagnosis of methyl malonicaciduria from 2013 to 2018

Concepción ÁA, Camayd VI, de León ONE, García GA, Martínez RL, Quintana HD
Full text How to cite this article

Language: Spanish
References: 12
Page: 41-45
PDF size: 143.82 Kb.


Key words:

diagnosis, methylmalonic acid, genetic diseases inborn.

ABSTRACT

Foundation: methylmalonic aciduria is one of the most frequent organic acidurias and groups together a set of genetic defects, characterized by the excretion of elevated levels of urinemethyl malonic acid. The excretion of this metabolite may or may not be accompanied by elevated homocysteine levels depending on the affected metabolic pathway.
Objective: to describe the implementation of a laboratory methodology that combines methylmalonic acid and homocysteine in the differential diagnosis and monitoring of methylmalonic aciduria in the period from 2013 to 2018.
Methods: for patients with an increase in methylmalonic acid in the organic acid profile, homocysteine was quantified in plasma and urine. The identification of methylmalonic acid was performed by gas chromatography / mass spectrometry, while the homocysteine quantification by high performance liquid chromatography.
Results: chromatographic methods allowed the identification and quantification of methylmalonic acid and homocysteine, respectively. Homocysteine was quantified in seven patients with increased levels of methylmalonic aciduria. Homocysteine levels in four of them were higher than normal values, suggesting aciduria combined with homocystinuria. Three of the patients with combined methylmalonic aciduria under treatment showed a decrease in the levels of both metabolites, corresponding to a satisfactory evolution.
Conclusions: simultaneous determination of both markers allowed differential diagnosis and biochemical monitoring of this disease.


REFERENCES

  1. Valle D, Antonarakis S, Ballabio A, Beaudet A, Mitchell GA. The Online Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill Education; 2015

  2. Concepción A, Camayd I, León NE, García A, Tamayo V, Quintana D. Introducción de la homocisteína como marcador en el diagnóstico diferencial de la aciduria metilmalónica [Internet]. La Habana: Congreso de Genética Comunitaria; 2017 [citado 26 Sep 2018]. Disponible en: http://geneticacomunitaria2017.sld.cu/index.php/ gencom/2017/paper/view/497

  3. ORPHA. Acidemia metilmalónica resistente a la vitamina B12 tipo mut- [Internet]. Mississippi: ORPHA; 2016 [citado 8 Jun 2018]. Disponible en: https://www.orpha.net/consor/cgi-bin/OC_Exp.php? Expert=79312&lng=ES

  4. Baumgartner MR, Hörster F, Dionisi C, Haliloglu G, Karall D, Chapman KA, et al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2014;9(1):130

  5. Horster F, Baumgartner M, Viardot C, Suormala T, Burgard P, Fowler B, et al. Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB). Pediatr Res. 2007;62(2):225-30

  6. Camayd I, Nuevas L, Concepción A. Diagnóstico bioquímico de acidurias orgánicas en Cuba: periodo 2008-2013. Acta Bioquím Clín Latinoam. 2015;49(2):209-14

  7. European MassBank. High Quality Mass Spectral Database [Internet].European MassBank: MassBank Project; 2017 [citado 29 Jun 2018]. Disponible en: https://massbank.eu/MassBank/

  8. Concepción A, Camayd I, Nuevas L. Validación de un método para la cuantificación de homocisteína total en plasma por HPLC. Rev Lab Clin. 2016;9(2):40-7

  9. Human Metabolome Database. The Human Metabolome Database for 2018 [Internet]. Canadá: Canadian Institutes of Health Research; 2018 [citado 27 Nov 2019]. Disponible en: http://www.hmdb.ca/

  10. Sloan JL, Carrillo N, Adams D, Venditti CP. Disorders of Intracellular Cobalamin Metabolism [Internet]. Seattle: University of Seattle; 2008 [citado 23 Oct 2019]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/20301503

  11. Haas RRH, Parikh S, Falk MJ, Sanetod RP, Wolfe NI, Darinf N, et al. Enfermedad mitocondrial: abordaje práctico para los médicos. Pediatría [revista en Internet]. 2007 [citado 19 Dic 2019];64(6):[aprox. 10p]. Disponible en: https://www.elsevier.es/es-revista-pediatrics-10-a rticulo-enfermedad-mitocondrial-abordaje-practic o-medicos-13114053

  12. Fowler B, Leonard JV, Baumgartner MR. Causes of and diagnostic approach to methylmalonic acidurias. J Inherit Metab Dis. 2008;31(3):350-60




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Finlay. 2020;10